Alexion Pharm Inc (ALXN) Stock Analyst Ratings
NASDAQ:ALXN - Nasdaq -
ChartMill assigns a Buy % Consensus number of 66% to ALXN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 180.9. This target is -0.87% below the current price.
ALXN was analyzed by 13 analysts. The buy percentage consensus is at 66. So analysts seem to be have mildly positive about ALXN.
In the previous month the buy percentage consensus was at a similar level.
ALXN was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.